Legal Disclaimer
1. NO WARRANTY
Protherics PLC and its subsidiary companies (Protherics) are providing this site on an "as is" basis for general information and public relations purposes only, and make no representations, warranties or undertakings of any kind with respect to this site, including with respect to its condition, quality, performance, suitability, reliability or fitness for any purpose, or the freedom from viruses of the content contained in the site (including details of Protherics PLC's share price, any text, graphics, advertisements and links), that such content is accurate, up to date, uninterrupted, error free or complete, or with respect to any use made of this site or that content. To the greatest extent permissible by applicable laws Protherics excludes all such representations, warranties and undertakings that may otherwise be implied with respect to this site, its content or the use any user of this site makes of this site or that content.
2. EXCLUSION OF LIABILITY
USERS OF THIS SITE ARE SOLELY RESPONSIBLE FOR THEIR ACCESS TO THIS SITE, THE USE TO WHICH THEY PUT THIS SITE OR THE USE THEY MAKE OF THIS SITE OR ITS CONTENT.
TO THE GREATEST EXTENT PERMISSIBLE BY APPLICABLE LAWS PROTHERICS EXCLUDES ANY AND ALL LIABILITY WITH RESPECT TO THIS SITE, ITS CONTENT OR THE USE OF THIS SITE OR ITS CONTENT, INCLUDING ANY CONSEQUENTIAL, SPECIAL, SECONDARY OR INDIRECT LOSS OR DAMAGE OR ANY DAMAGE TO GOODWILL OR PROFITS OR ANY LOSS OF ANTICIPATED SAVINGS INCURRED, HOWSOEVER ARISING, AND ANY AND ALL LIABILITY ARISING OUT OF OR IN CONNECTION WITH ACCESS TO, USE OF OR INABILITY TO USE THIS SITE, OR IN CONNECTION WITH ANY FAILURE OF PERFORMANCE, ERROR, OMISSION, INTERRUPTION, DEFECT, DELAY IN OPERATION OR TRANSMISSION WITH RESPECT TO THIS SITE, ANY COMPUTER VIRUS OR LINE OR ANY SYSTEM FAILURE, EVEN IF PROTHERICS OR ITS EMPLOYEES OR AGENTS ARE ADVISED OF THE POSSIBILITY OF SUCH LIABILITY.
3. NO MEDICAL ADVICE
Medical information on this site is not intended as a substitute for informed medical advice and users of this site must consult a suitably qualified healthcare professional on any specific matter which is addressed by any content of this site before taking any action or making any decision. Nothing on this site should be construed as the giving of medical advice.
4. NO INVESTMENT ADVICE
This web site may contain so-called "forward-looking statements". These statements may be identified by introductory words such as "expects," "plans," "will," "estimates," "forecasts," "projects," or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements are used in this site in discussing Protherics' growth strategy, operating and financial goals, plans relating to regulatory submissions and approvals or development programmes.
Nothing on this site, including any forward-looking statement, should be construed as the giving of advice, or the making of any recommendation, for investment purposes. This site's contents should not be relied upon as the basis for any investment decision or action.
Nothing on this site is an invitation to invest or otherwise deal in shares or other securities of Protherics PLC or any other company.
5. INVESTMENT AND PRODUCT RISKS
Without prejudice to the above exclusions, users of this site should be aware that many factors may cause Protherics PLC's performance and prospects to differ from the forward-looking statements on this site, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Those and other risks are described in Protherics PLC's filings with the Securities and Exchange Commission (SEC), copies of which are available on the SEC's website at www.sec.gov or may be obtained upon request from the Protherics PLC. No forward-looking statement is a guarantee.
Additionally, the clinical evaluation, manufacturing and marketing of Protherics' products are subject to regulation by government and regulatory agencies in all countries. Of particular importance is the requirement to obtain and maintain approval for a product from the applicable regulatory authorities to enable it to be marketed. Such approval requires the clinical evaluation of trial and other data relating to the safety, quality and efficacy of a product. Many countries, including the United States and the United Kingdom, have very high standards of technical appraisal and, accordingly, the clinical trial process and obtaining of regulatory approval is, in most cases, costly and very lengthy. The time taken to obtain such approval varies, but it can be up to five years from the date of application.
There can be no assurance that any of Protherics' proposed products will complete successfully the clinical trials process or that regulatory approvals to manufacture and market its product candidates will be obtained in a timely manner or at all. Furthermore, if regulatory approval is obtained, including where it has already been obtained, the relevant product and its manufacture are subject to continual review and there can be no assurance that such approval will not be withdrawn or restricted. Changes in legislation, regulatory policies or the discovery of problems with a product or its manufacture may result in the imposition of restrictions on that product or manufacture, or may otherwise have an adverse effect on Protherics' business.
Forward-looking statements on this site, statements concerning Protherics' products and the past performance of Protherics, or the shares or other securities of Protherics PLC, must not be relied on as a guide to the future performance of Protherics or its securities.
6. VARIATION OF CONTENT
Protherics reserves the right in its absolute discretion, at any time and without notice to remove, amend or vary, with immediate effect, any of the content which appears on any page of this site, including any of these terms and conditions.
7. USE OF CONTENT
You may store, manipulate, analyse, reformat, print and display the content of this site solely for your own, non-commercial and personal use, provided that all copies and print-outs of that content bear the copyright, author attribution, and other proprietary, notices and disclaimers displayed on it on this site.
Other than as specified above, neither this site nor any of its contents may be modified or copied in whole or part in any form, including by framing, incorporation into other web sites or other publications, or be used to create any derivative work. In particular, in no event are you permitted to publish, re-transmit, re-distribute or otherwise re-produce any of the content which appears on any page of this site in any format, or to use any such content in connection with any business or commercial enterprise.
Protherics cannot guarantee that users of this site have any right to use content available on it which is owned by any third party, and that third party's permission will be required before their content can be used.
No links to this site may be included in any other web site without Protherics' prior written permission.
8. COPYRIGHT
All design, text, graphics and the selection or arrangement thereof in the pages of this site and the screens displaying the pages of this site are the copyright of Protherics unless otherwise indicated, and none of the copyright or author attribution notices appearing on that content may be altered or removed without Protherics' prior written permission.
Nothing on this site should be construed as granting any right or licence to any materials or content contained or referenced on this site and the companies comprising Protherics reserve all rights.
9. TRADE MARKS
References to Protherics trademarks are made throughout this site. The following are registered trademarks of Protherics and/or its affiliated companies or trademarks for which application for registration has been made.
Protherics™ is pending in Europe and the USA. TAb® is a registered trade mark of Protherics Inc. in Australia, Canada, Finland, France, Germany, Italy, Japan, Norway, Spain, Sweden and the USA; TAb™ is pending in Denmark and the UK. CroFab™ is pending in Europe and in the USA. CytoFab ™ is a registered trade mark of Protherics Inc. in Australia, Canada, Denmark, Finland, France, Germany, Italy, Japan, Norway, Spain, Sweden and the UK; CytoFab™ is pending in the USA. TriTAb® is a registered trade mark of Protherics Inc. in Australia, Canada, Denmark, Finland, France, Germany, Italy, Norway, Spain, Sweden, the UK and the USA. ViperaTAb® is a registered trade mark of Protherics Inc. in Austria, Benelux, Denmark, Finland, France, Germany, Greece, Italy, Norway, Portugal, Spain, Sweden, Switzerland and the UK; ViperaTAb™ is pending in Ireland. EchiTAb™ is pending in Nigeria. PolongaTAb™ is pending in Sri Lanka.
None of Protherics' trade marks, service marks, company names or logos may be used without Protherics' prior written permission.
All other trademarks, service marks, company names or logos and copyrights used on this site are the property of their respective holders, and Protherics cannot guarantee that users of this site have any right to use any of them.
10. THIRD PARTY WEBSITES
For users' convenience, this site may contain hypertext links to third party owned websites . Protherics has no control over any websites which may be accessed or available through those links and does not endorse, sponsor, recommend or otherwise accept any responsibility for such third party websites or their content or availability. In particular, Protherics does not accept any liability for any infringement of any person's intellectual property rights by, or liability arising out of any information or opinion contained on, any such third party website.]
11. COOKIES
Protherics uses cookies, small pieces of information stored in the memory of the browser of any user of this site, to enable Protherics to collect information about that user's use of it. Protherics uses cookies (a) to develop a profile about user preferences on this site; (b) to develop and improve this site and navigation through it; (c) to personalise users' experiences when using this site; and (d) to compile statistics concerning use of this site in general. Protherics reserves the right to use future tracking technologies of a similar nature in future.
The Information Advertising Bureau's website, located at www.allaboutcookies.org , provides in-depth information about cookies and how users can remove or disable cookies from their browser.
By using this site users agree to the use of cookies as described above.
© Protherics PLC, 2008